We are a Swiss medical device company

Our focus: meeting important unmet needs in the practice of medicine.

Our principles

Passion

We are physicians, engineers, and business professionals driven by the promise of solving unmet needs in healthcare.

Precision

Our founder, Dr. med. U. Baumann, has spent more than 20 years perfecting our technology.

Purpose

We are singularly committed to improving diagnostics and patient care.

Meet the
team

Vincent Baumann

Chief Executive Officer

Healthcare leader with 20 years of experience

Ulrich Baumann, MD

Chief Medical Officer

Passionate medical doctor for 40+ years

Francois Monory

OPEX-Advisor & Board Member

Global leader & expert in medical device manufacturing and operations; 20+ years of experience with the No. 1 medical device manufacturer

Aswin Bhuvanendran

Chief Commercial Officer

Commercial leader in life sciences for 15+ years

Patrick Roth

Chief Operations Officer

25 years in MedTech and other industries

Robin Demesmaeker

Chief Technology Officer

Medtech innovator and accelerator for 8+ years

Craig Sisson

Medical Advisor

Peter Frei, MBE

IP Manager

Unique combination of technical and IP know-how for 30 years

Charlotte Moerman

Clinical Affairs Manager

EPFL bioengineering & PhD in Neuroscience specialized in applied research and novel medical devices.

Simone Troxler

Head of Medical Affairs

Federico Milani

Head of Software Development

Software engineer with 4+ years of specialized expertise in Artificial Intelligence and Computer Vision

Yan Pellouchoud

Chief Procurement Officer

Expercienced and creative Supply Management Leader in MedTech for more than 20 years.

André Steiner

Head of Sales

26 years in global MedTech sales organisations

Karin Roth

Communication

Broad experience in scientific and MedTech communication

Jurjen Zoethout

Regulatory Advisor

Business-oriented analytical and strategic thinker with 20+ years of international medical device project team management, R&D, quality, regulatory and clinical expertise.

Our story

How we got to today

2011

Dr. med. Ulrich Baumann develops the concept of measuring the venous pressure non-invasively. Initial feasibility tests show very promizing results.

2011

VeinPress Ltd. is founded in Münsingen, Switzerland.

2012

First scientific results are published by various research groups in renowned scientific journals. Publications have been issued by the university hospitals in Basel, Zurich and Bern, among others.

2013

The VeinPress prototype is further developed in collaboration with ETH Zurich and the University Hospital of Basel.

2014

VeinPress wins the prestigious Swiss Medtech Award together with its scientific partners ETH Zurich and the University Hospital Basel.

2015

The Compremium method takes flight - NASA starts first tests on the ground in their research labs at Houston, TX and in Cologne, Germany. The tests were followed by intensive testing in parabolic flights with NASA crew members out of Bordeaux, France.

2015

PD Dr. med. Richard M. Sellei, Chief Physician of the Department of Orthopaedic and Trauma Surgery at Sana Klinikum Offenbach, publishes first study on the method of measuring compartment elasticity using pressure related ultrasound to identify patients with potential compartment syndrome.

2016

NASA initiates a series of scientific tests in space on the International Space Station. Other medical applications are explored by various independent research groups.

2019

Three studies on the use of the VeinPress method on elevated compartment pressure of the leg are published. NASA publishes the study on the Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight.

2020

Compremium AG is founded in Muri b. Bern, Switzerland.

2021

Scientific collaboration starts with Maxima Medisch Center and Dr. med. Marc Scheltinga in Veldhoven, Netherlands.

2022

Andrea Rytz, CEO of the Schulthess Klinik in Zurich initiates the scientific collaboration with Compremium.

2022

The first Compremium Compressibility Forum takes place at the PostFinance Arena in Bern.

2022

FDA clearance study conducted at the University Hospital, Inselspital in Bern by Dr. med. Beat Lehmann, Deputy Chief Physician and Head of the Emergency Department and his team.

2023

Clinical partnership established with Charité - Universitätsmedizin Berlin.

2023

Compremium receives FDA clearance for the CPMX1 System.

2024

CPMX1 is now MIL-STD 810H compliant and ready for duty! MIL-STD-810H is a military standard developed by the U.S. Department of Defense to test the resistance of equipment to environmental conditions.

Our story

Help us shape the future of diagnostics.

Open Positions

Clinical Affairs Specialist

Medical Technology
See Details

QARA Specialist

Medical technology
See Details

System Architect

Medical System Development
See Details

Reach out for additional positions

For inquiries reach out to: 

careers@compremium.ch